Safety of Bryostatin in Patients With MS

Clinical trial NCT06190912 · TERMINATED

Trial details

NCT number: NCT06190912
Sponsor: Robert Fox
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2024-06-26
Primary completion: 2025-03-15
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.